SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 939
AS - Asia 496
EU - Europa 355
SA - Sud America 167
AF - Africa 50
Totale 2.007
Nazione #
US - Stati Uniti d'America 918
SG - Singapore 198
BR - Brasile 134
VN - Vietnam 105
RU - Federazione Russa 78
CN - Cina 77
IT - Italia 53
SE - Svezia 51
IE - Irlanda 46
HK - Hong Kong 44
CI - Costa d'Avorio 27
DE - Germania 27
FR - Francia 26
IN - India 25
UA - Ucraina 23
GB - Regno Unito 17
FI - Finlandia 13
CA - Canada 11
IQ - Iraq 8
AR - Argentina 7
MX - Messico 7
VE - Venezuela 7
ZA - Sudafrica 7
ID - Indonesia 6
BD - Bangladesh 5
CO - Colombia 5
DZ - Algeria 5
EC - Ecuador 5
NL - Olanda 5
TR - Turchia 5
MA - Marocco 4
PL - Polonia 4
AT - Austria 3
BO - Bolivia 3
CL - Cile 3
JP - Giappone 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
KR - Corea 2
LT - Lituania 2
NP - Nepal 2
SV - El Salvador 2
TH - Thailandia 2
BF - Burkina Faso 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.007
Città #
Ashburn 240
Singapore 127
Chandler 86
San Jose 56
Dublin 46
Fairfield 44
Hong Kong 43
Ho Chi Minh City 31
New York 31
Dallas 30
Boardman 28
Hanoi 28
The Dalles 28
Abidjan 27
Jacksonville 25
Beijing 24
Houston 21
Lawrence 20
Princeton 20
Lauterbourg 17
Turin 16
Los Angeles 15
Moscow 13
San Diego 13
Seattle 13
Munich 12
Wilmington 12
Washington 11
Chennai 9
Woodbridge 9
São Paulo 8
Turku 8
Cambridge 7
London 7
Council Bluffs 6
Rio de Janeiro 6
Ann Arbor 5
Buffalo 5
Da Nang 5
San Mateo 5
Baghdad 4
Boston 4
Denver 4
Haiphong 4
Helsinki 4
Johannesburg 4
Macerata 4
Montreal 4
Orem 4
Santa Clara 4
Warsaw 4
Columbus 3
Curitiba 3
Frankfurt am Main 3
Hefei 3
La Paz 3
Mumbai 3
Paris 3
Porto Alegre 3
Quito 3
San Francisco 3
Tokyo 3
Aparecida de Goiânia 2
Aracaju 2
Atlanta 2
Barranquilla 2
Belo Horizonte 2
Bragança Paulista 2
Brooklyn 2
Bến Tre 2
Casablanca 2
Chicago 2
Contagem 2
Culiacán 2
Eelde 2
Guangzhou 2
Guaratinguetá 2
Hải Dương 2
Jaú 2
Joinville 2
La Plata 2
Lagoa Santa 2
Manchester 2
Marche 2
Mexico City 2
Mountain View 2
Nasiriyah 2
Ninh Bình 2
Oklahoma City 2
Oran 2
Palermo 2
Phoenix 2
Pune 2
Quảng Ngãi 2
Quận Ba 2
Redwood City 2
Riyadh 2
San Salvador 2
Secaucus 2
Shanghai 2
Totale 1.310
Nome #
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 136
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 131
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 121
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 119
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 112
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 109
Role of STAT3 pathway in genitourinary tumors 109
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 106
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 101
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 100
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 96
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 91
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 86
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 85
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 84
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 84
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 82
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 81
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 79
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 73
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 71
Totale 2.056
Categoria #
all - tutte 11.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 8 9 2
2021/2022134 4 5 4 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/2025432 29 24 5 10 23 55 86 20 69 16 36 59
2025/2026880 95 47 47 74 129 62 172 101 86 67 0 0
Totale 2.056